Home › Type 2 Diabetes › NCT06516640
Type 2 Continuous Glucose Monitoring Academy
Randomized Control Trial Evaluating the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes
Who can join
Ages 8 to 21 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Current age of 8-21 years; 2. T2D diagnosis; 3. Able to speak, read, and write English or Spanish Exclusion Criteria: a. Known history of medical adhesive allergies;
About the study
The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D):
* The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies. * The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics. * The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics.
Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.
What is being tested
- Continuous Glucose Monitoring Academy (behavioral)
- Standard Education (behavioral)
Sponsor: Children's Hospital Los Angeles · Participants: 60 · Started: Jun 23, 2025
Contact the study team
- Natalia Garban · Phone: 3233611359
- Rebecca Barber · Phone: 3233611359
Official record on ClinicalTrials.gov — NCT06516640
Locations in the U.S.
| California | Children's Hospital Los Angeles, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.